Korean beauty device makers see rise in overseas sales on growing demand

2023. 8. 30. 11:54
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

Medicube Age-R. [Courtesy of APR]
South Korean beauty device makers are stepping up efforts to target the global market as more attention is given to K-beauty.

Korean beauty tech company APR said on Tuesday that its beauty device brand Medicube Age-R achieved sales of 100,000 units overseas in the first half of this year, accounting for about 80 percent of last year’s entire sales.

Following the sale of 600,000 beauty devices last year, APR sold 500,000 units at home and abroad in the first half of this year, with 25 to 30 percent of those sales coming from overseas, the company said.

As a result, overseas sales in the first half of this year exceeded 80 billion won ($60.67 million), up by more than 20 percent from the same period last year.

“The main contributor to the increase in overseas sales is the U.S., which has the largest beauty market in the world. Sales in the U.S. expanded by more than 80 percent from the same period last year,” said an official from APR. “Although the sales volume was second only to Japan, it was number one in terms of booster healer products, which were very popular.”

Booster healers are devices that help basic skincare ingredients absorb deeper into the skin for a radiant glow. Recently, pop star Justin Bieber’s wife, Hailey Bieber, certified her use of booster healer.

Dualsonic, a beauty device made by JION MEDITECH Co., is also capitalizing on the popularity of K-beauty. The device is exported to more than 30 countries including the U.S., China, France, and Spain.

Equipped with the first patent-certified dual-layer HIFU technology in Korea, Dualsonic provides elasticity to the skin by focusing ultrasound on two layers of the skin.

LUKINS, a beauty device presented by MOSTX, is also looking to expand overseas.

Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지

이 기사에 대해 어떻게 생각하시나요?